Cadence Bank NA’s Alexion Pharmaceuticals ALXN Stock Holding History

Cadence Bank NA’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,369	Closed	-$435K	–	220
2021 Q2	$435K	Sell	2,369 -161	-6%	-$27.6K	0.13%	140
2021 Q1	$387K	Sell	2,530 -149	-6%	-$23K	0.12%	142
2020 Q4	$418K	Hold	2,679	–	–	0.15%	132
2020 Q3	$307K	Buy	2,679 +167	+7%	+$18K	0.12%	144
2020 Q2	$281K	Buy	+2,512	New	+$267K	0.12%	144
2020 Q1	–	Sell	-1,875	Closed	-$203K	–	182
2019 Q4	$203K	Buy	+1,875	New	+$201K	0.07%	175

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Cadence Bank NA's ALXN Position: Q3 2021 in Review

Cadence Bank NA sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,369 shares — an estimated $435K sold.

Cadence Bank NA first reported a position in ALXN in Q4 2019 and held it in 6 quarters. The position peaked at $435K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

Cadence Bank NA reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Cadence Bank NA sold 2,369 Alexion Pharmaceuticals shares in Q3 2021, an estimated $435K.
Cadence Bank NA first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 6 quarters.
Cadence Bank NA's Alexion Pharmaceuticals position peaked at $435K in Q2 2021.
7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Cadence Bank NA's 13F filing for Q3 2021, filed 22 Oct 2021.